Rats bearing a methylcholanthrene induced fibrosarcoma showed a decrease in thyroid weight, a decreased responsiveness to the goitrogenous effect of PTU and a significant decrease in 24 hour thyroidal 131I uptake. The thyroid of the tumourous rats was also shown to have a marked inability to synthesize thyroid hormones. The effects on the thyroid were found to accumulate proportionally to the time during which the tumour grew in the rat, and lead to a fibrous and degenerative invasion of the thyroid gland. In the rats bearing tumours, 1) the plasma and the pituitary TSH concentrations were within normal range; 2) large doses of exogenous TSH were able to stimulate the thyroid; 3) injection of saline extracts from the tumour elicited thyroid changes similar to those produced by the tumour. It is concluded from these data that the tumour produces an unusual hypothyroidism in the rat, which is caused by a substance elaborated by the tumour. The substance destroys progressively the thyroid tissue, leaving less and less thyroid parenchyma to respond to TSH and to secrete thyroid hormones. The substance seems to interfere with TSH at the thyroid level.
their 24 hours radioiodine thyroidal uptake was decreased, as well as the con¬ centration of radioiodinated plasma iodothyronine (Claus et al. 1962 ).
The results obtained in these experiments show that the effect of the fibro¬ sarcoma upon the thyroid is due to the secretion by the tumour of a substance that has a direct effect upon the thyroid, or induces the formation of an endo¬ genous substance that will in turn act upon the thyroid, and modify its response to endogenous thyrotrophin.
MATERIALS AND METHODS

I. Animals
Male Sprague Dawley rats (Holtzman Co., Houston, Texas and Cheek Jones Farms, Houston, Texas) weighing 125 to 200 g were used throughout these studies.
The transplanted fibrosarcoma has been described previously. The successive trans¬ planted tumours were labelled as follows: MT. A (original tumour transplant), MT. (original tumour transplant kept at the Memorial Hospital Vivarium, Houston), MT. C (original tumour transplant kept at Cheek Jones Farms). The tumour was transplanted into the right groin of the rat.
II. Diet
Unless otherwise indicated, the rats were maintained on Purina Laboratory Chow and tap water ad libitum. In order to induce a goiter, they were fed a Remington Diet containing 0.15 per cent propylthiouracil (General Biochemical. Chagrin Falls, Ohio). This was subsequently referred to as the goitrogenic diet.
III. Treatments 1. Thyrotrophin* (TSH) was injected subcutaneously (s. c.) in doses of 0.5 USP units in 1 ml of saline. In one experiment the injections were made on the 24th, 25th, 26th. 27th and 28th day following the tumour transplantation while in another, day 24 was omitted. The rats included in the second experiment received 10 pc** 131I 24 hours before sacrifice.
2. Myleran*** was injected intraperitoneally (i. p.) as suggested by Haddow Se Tinimis (1953) in doses of 1.5 mg per kg body weight. 7 days after the transplantation of the tumour. 3. Cytoxan**** in saline (100 mg in 20 ml) was injected i. p. (45 mg and 34 mg per kg body weight), on days 7 and 14 after tumour transplantation (Arnold et al. 1958 : Lane 1960 A saline extract and a hydrolyzed saline extract were also prepared. Each gram of chopped frozen tumour was homogenized in the cold with 3 ml of saline. A few crystals of ethylene diamine tetraacetic acid were added. The soluble fraction was lyophilized. An aliquot of the lyophilized powder was hydrolyzed by refluxing for 16 hours with 5.7 HCl (Haurowitz 1963) . The lyophilized and the hydrolyzed lyo¬ philized extracts were each dissolved in warm saline and filtered (Putnam 1953 (1964) . Saline extracts of 5 hypophysis were injected at 3 dose levels (1/1800, 1/600 and 1/200 dilutions) in volumes of 0.3 ml. For the measurement of plasma TSH levels, plasma pooled from 5 rats was injected at a single dose level (0.5 ml for rats on a normal diet and 0.1 ml in a volume of 0.5 ml for rats on a goitrogenic diet), saline and two doses of USP thyrotrophin reference standard, 0.6 and 0.2 milliunits, were injected in 0.5 ml volume.
The comparison of the TSH activity of the pituitary gland from a normal versus tumourous rat was made with a 6 point assay (Bliss 1952) . The adjusted responses ob¬ tained in the mice were compared to those of saline with the multiple comparison test of Dunnett (1955) . Approximate potencies of the plasma samples, expressed in milli¬ units TSH reference standard per 100 ml, were further calculated in multiple 3 point assays (2 doses of standard, 1 dose of unknown) as originally described by Gaddum (1953) (Lison 1958 Table 4 B. The body weight was the same in all groups, the thyroid weight and the 131I uptake was signi¬ ficantly decreased in the rats treated with the saline extracts whereas the 131I uptake was slightly elevated in the group that received injection of the hydrolyzed saline extract. Thus, there is a greater difference between the effect of the saline tumour extract before and after hydrolysis than between the saline tumour extract and the saline control. Histological examination of thyroid sections stained with haematoxylin and eosin showed that the thyroid of the rats who received the saline tumour extracts were quiescent (Fig. 4) (Claus et al. 1962 ). These secreted hormones were probably sufficient to insure a normal feedback to the hypophysis and the thyroid.
The aetiology of this hypothyroidism does not seem related to any of the ones classically described (Means et al. 1964) . Money (1955) and Begg (1958) Reichlin (1957) (Claus et al. 1962) .
The plasma of the tumourous rats may have contained an abnormal iodinated compound with an inhibitory effect upon the thyroid (Money et al. Ì959) . However, radioautographic studies of the plasma of tumourous rats failed to detect any such produce (Claus et al. 1962 ).
The tumourous rats may have a decreased responsiveness to TSH. This was suggested by the occurrence of thyroidal activation after injection of large doses of TSH into tumour bearing rats and by the lack of activity observed in the thyroid of the rats following multiple injections of tumour extracts.
If the effects of the fibrosarcoma upon the thyroid are reproduced by in¬ jection of tumour extracts in the intact rat, the agent responsible for the hypo¬ thyroidism must be elaborated by the tumour.
The mechanism of the hypothyroidism which appears in the rats as a result of the growth of a methylcholanthrene induced fibrosarcoma can be described as follows: a substance X destroys progressively the thyroid tissue leaving less and less thyroid parenchyma to respond to TSH and to secrete triiodothyronine and thyroxine. Substance X is present in saline tumour extract but not in the acetic acid extract of a tumour acetone powder or in the hydrolyzed saline tumour extract; thus, it is likely a sensitive molecule which does not with¬ stand strong acid hydrolysis. In early stages X seems to interfere with TSH and to act as a TSH antagonist.
Many non-endocrine tumours were found to induce hormone like effect in their host and in experimental animals injected with extracts from these tumours (Lipsett et al. 1964) . There is no report of substances elaborated by non-endocrine malignant tumours that has an anti-hormone like effect.
